These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15694536)

  • 21. Good effect of IgY against Pseudomonas aeruginosa infections in cystic fibrosis patients.
    Nilsson E; Larsson A; Olesen HV; Wejåker PE; Kollberg H
    Pediatr Pulmonol; 2008 Sep; 43(9):892-9. PubMed ID: 18680179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoantibodies against bactericidal/permeability-increasing protein in cystic fibrosis patients: comment on the article by Hoffman and Specks.
    Taccetti G; Campana S; Marianelli L; Procopio E; Turchini S
    Arthritis Rheum; 1999 Jun; 42(6):1305-6. PubMed ID: 10366132
    [No Abstract]   [Full Text] [Related]  

  • 23. [Genotype and phenotype of gastrointestinal symptoms analysis in children with cystic fibrosis].
    Iwańczak F; Smigiel R; Stawarski A; Pawłowicz J; Stembalska A; Mowszet K; Sasiadek M
    Pol Merkur Lekarski; 2005 Feb; 18(104):205-9. PubMed ID: 17877132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary infection in mild variant cystic fibrosis: implications for care.
    Lording A; McGaw J; Dalton A; Beal G; Everard M; Taylor CJ
    J Cyst Fibros; 2006 May; 5(2):101-4. PubMed ID: 16426904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum zinc concentrations in cystic fibrosis patients aged above 4 years: a cross-sectional evaluation.
    Van Biervliet S; Van Biervliet JP; Vande Velde S; Robberecht E
    Biol Trace Elem Res; 2007 Oct; 119(1):19-26. PubMed ID: 17914215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post-operative infections in cystic fibrosis and non-cystic fibrosis patients after lung transplantation.
    Bonvillain RW; Valentine VG; Lombard G; LaPlace S; Dhillon G; Wang G
    J Heart Lung Transplant; 2007 Sep; 26(9):890-7. PubMed ID: 17845927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance.
    De Baets F; Schelstraete P; Van Daele S; Haerynck F; Vaneechoutte M
    J Cyst Fibros; 2007 Jan; 6(1):75-8. PubMed ID: 16793350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antineutrophil cytoplasmic antibodies and associated diseases].
    Sghiri R; Meddeb H; Bouguila J; Jarray M; Bahri F; Nouira R; Zellama D; Achour A; Essoussi AS; Harbi A; Ghedira I
    Pathol Biol (Paris); 2009 Jul; 57(5):398-402. PubMed ID: 18834675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relation between fatty acid composition and clinical status or genotype in cystic fibrosis patients.
    Van Biervliet S; Vanbillemont G; Van Biervliet JP; Declercq D; Robberecht E; Christophe A
    Ann Nutr Metab; 2007; 51(6):541-9. PubMed ID: 18227622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasculitis complicating cystic fibrosis.
    Finnegan MJ; Hinchcliffe J; Russell-Jones D; Neill S; Sheffield E; Jayne D; Wise A; Hodson ME
    Q J Med; 1989 Jul; 72(267):609-21. PubMed ID: 2608880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis.
    Finkielman JD; Lee AS; Hummel AM; Viss MA; Jacob GL; Homburger HA; Peikert T; Hoffman GS; Merkel PA; Spiera R; St Clair EW; Davis JC; McCune WJ; Tibbs AK; Ytterberg SR; Stone JH; Specks U;
    Am J Med; 2007 Jul; 120(7):643.e9-14. PubMed ID: 17602941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased total serum coenzyme-Q10 concentrations: a longitudinal study in children with cystic fibrosis.
    Laguna TA; Sontag MK; Osberg I; Wagener JS; Accurso FJ; Sokol RJ
    J Pediatr; 2008 Sep; 153(3):402-7. PubMed ID: 18534204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth and long-term lung function in cystic fibrosis: a longitudinal study of patients diagnosed by neonatal screening.
    Assael BM; Casazza G; Iansa P; Volpi S; Milani S
    Pediatr Pulmonol; 2009 Mar; 44(3):209-15. PubMed ID: 19230003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical changes of patients with cystic fibrosis during transition from pediatric to adult care.
    Duguépéroux I; Tamalet A; Sermet-Gaudelus I; Le Bourgeois M; Gérardin M; Desmazes-Dufeu N; Hubert D
    J Adolesc Health; 2008 Nov; 43(5):459-65. PubMed ID: 18848674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early rise of anti-pseudomonas antibodies and a mucoid phenotype of pseudomonas aeruginosa are risk factors for development of chronic lung infection--a case control study.
    Pressler T; Frederiksen B; Skov M; Garred P; Koch C; Høiby N
    J Cyst Fibros; 2006 Jan; 5(1):9-15. PubMed ID: 16412706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antineutrophil cytoplasmic antibodies directed against bactericidal/permeability-increasing protein detected in children with cystic fibrosis inhibit neutrophil-mediated killing of Pseudomonas aeruginosa.
    Sedivá A; Bartůnková J; Bartosová J; Jennette C; Falk RJ; Jethwa HS
    Microbes Infect; 2003 Jan; 5(1):27-30. PubMed ID: 12593970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of allergic bronchopulmonary aspergillosis in cystic fibrosis in an area with a high frequency of atopy.
    Skov M; McKay K; Koch C; Cooper PJ
    Respir Med; 2005 Jul; 99(7):887-93. PubMed ID: 15939251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neonatal screening for cystic fibrosis does not affect time to first infection with Pseudomonas aeruginosa.
    Baussano I; Tardivo I; Bellezza-Fontana R; Forneris MP; Lezo A; Anfossi L; Castello M; Aleksandar V; Bignamini E
    Pediatrics; 2006 Sep; 118(3):888-95. PubMed ID: 16950978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study.
    Hansen CR; Pressler T; Koch C; Høiby N
    J Cyst Fibros; 2005 Mar; 4(1):35-40. PubMed ID: 15752679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Profile and factors determining outcome in a cohort of cystic fibrosis patients seen at the Aga Khan University Hospital, Karachi, Pakistan.
    Shah U; Moatter T; Bhutta ZA
    J Trop Pediatr; 2006 Apr; 52(2):132-5. PubMed ID: 16582405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.